Molecular Probes Introducing 14 new probes

Similar documents
HSL-Advanced Diagnostics 2018 / 19 Test & Service List

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

HER2 ISH (BRISH or FISH)

Assessment Run B HER-2 IHC. HER-2/chr17 ratio**

Digital Pathology and CAP Guidelines

Dr. dr. Primariadewi R, SpPA(K)

HER2 status assessment in breast cancer. Marc van de Vijver Academic Medical Centre (AMC), Amsterdam

ACMG/CAP Cytogenetics CY

IT S ABOUT TIME. IQFISH pharmdx Interpretation Guide THREEHOURSTHIRTYMINUTES. HER2 IQFISH pharmdxtm. TOP2A IQFISH pharmdxtm

Assessment Run B HER2 IHC

Journal of Breast Cancer

Nitta et al. Diagnostic Pathology 2012, 7:60

Workflow. Connecting the Pieces For Total Patient Care

Assessment Run B HER2 IHC

VENTANA MMR IHC Panel Interpretation Guide for Staining of Colorectal Tissue

HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer

HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)

HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer

Three Hours Thirty Minutes

Chapter 4 Cellular Oncogenes ~ 4.6 -

CINtec PLUS Cytology. Interpretation training

microrna Presented for: Presented by: Date:

HPV/p16 Analyte Control

Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR

ABBOTT MOLECULAR ONCOLOGY AND GENETICS

American Society of Cytopathology Core Curriculum in Molecular Biology

Anti-hTERT Antibody (SCD-A7)

Milestones in Her 2 Testing

Epstein Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature

Surgical Pathology Lab of the Future. Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc.

White paper Comparative analysis of H&E stain quality between the VENTANA HE 600 system and a traditional linear stainer

Quality in Control. ROS1 Analyte Control. Product Codes: HCL022, HCL023 and HCL024

Product Introduction

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

Breast cancer diagnostic solutions Deliver diagnostic confidence

PD-L1 Analyte Control DR

ZytoFast CMV Probe (Biotin-labeled)

Ventana s Approach to Lymphoma Biomarkers

Barriers to Understanding

SMH (Myosin, smooth muscle heavy chain)

VENTANA ALK (D5F3) CDx Assay

Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent

ONCO TEAM DIAGNOSTIC

The development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Version 2 of these Guidelines were drafted in response to published updated ASCO/CAP HER2 test Guideline Recommendations-

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx

Assessment Run GATA3

VENTANA ALK (D5F3) Rabbit Monoclonal Primary Antibody. ALK IHC Biomarker Testing Aiding in patient diagnosis

Original article. A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous

GENETIC TESTING FOR TARGETED THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)

Estrogen receptor (ER)

VENTANA PD-L1 (SP142) Assay Guiding immunotherapy in NSCLC

Human Papillomaviruses: Biology and Laboratory Testing

Estrogen receptor (ER)

Priti Lal, MD, 1 Paulo A. Salazar, 1 Clifford A. Hudis, MD, 2 Marc Ladanyi, MD, 1 and Beiyun Chen, MD, PhD 1. Abstract

WHO Prequalification of Diagnostics Programme PUBLIC REPORT

VENTANA PD-L1 (SP263) Assay Staining in Urothelial Carcinoma Interpretation Guide

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.

Detection of Anaplastic Lymphoma Kinase (ALK) gene in Non-Small Cell lung Cancer (NSCLC) By CISH Technique

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

MEDICAL POLICY. Proprietary Information of YourCare Health Plan

Results you can trust

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

In Situ Hybridization Immunohistochemistry

Know for sure! Your Power for Health. PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer.

Assessment Run CK19

Breast cancer: Antibody selection, protocol optimzation controls and EQA

Instant Quality FISH. The name says it all.

Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray

For the rapid, sensitive and accurate measurement of apoptosis in various samples.

GENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute

Expression of acid base transporters in the kidney collecting duct in Slc2a7 -/-

C H A R A C T E R I Z A T I O N O F T H E N O V E L D O M A I N W I T H N O N A M E G E N E I N C O L O N C A N C E R

ExpressArt FFPE Clear RNAready kit

NON-RECOMMENDED CERVICAL CANCER SCREENING IN ADOLESCENT FEMALES. HEDIS (Administrative)

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

MOLECULAR BASIS OF ONCOGENESIS

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at

Determination of HER2 Amplification by In Situ Hybridization. When Should Chromosome 17 Also Be Determined?

5 th July 2016 ACGS Dr Michelle Wood Laboratory Genetics, Cardiff

VENTANA PD-L1 (SP142) Assay

VDx: Unlocking Complex Diagnostics

Advantages and Disadvantages of Technologies for HER2 Testing in Breast Cancer Specimens

Nucleic Acid Testing - Oncology. Molecular Diagnosis. Gain/Loss of Nucleic Acid. Objectives. MYCN and Neuroblastoma. Molecular Diagnosis

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:

Supporting Online Material for

Molecular Diagnosis. Nucleic acid based testing in Oncology

Diagnostics Division. Daniel O Day COO Roche Diagnostics

Guideline. Associated Documents ASCO CAP 2018 GUIDELINES and SUPPLEMENTS -

Commissioning policies agreed by PCTs in Yorkshire and the Humber at Board meeting of YH SCG on December

October Billing and compliance. Coagulation. Immunohistochemistry. Immunology. Referral testing ICD 10

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx

Single and Multiplex Immunohistochemistry

Transcription:

Molecular Probes Introducing 14 new probes

Gene and Chromosome Probes Dual Colour ISH INFORM HER2 Dual ISH DNA Probe Cocktail Assay Product Part Number INFORM HER2 Dual ISH DNA Probe Cocktail 800-4422 05899826001 50 tests ultraview SISH DNP Detection Kit 800-098 05907136001 100 tests ultraview Red ISH DIG Detection Kit 800-505 05907128001 100 tests HybReady 780-4409 05917557001 250 dispenses ultraview Silver Wash II 780-003 05446724001 2L HER2 Dual ISH 3-in-1 Xenograft Slides 783-4422 05640300001 10 slides Interpretation Guide Please contact your local representative The INFORM HER2 Dual ISH DNA Probe Cocktail is designed to quantitatively detect amplification by light microscopy of the HER2 gene via two colour chromogenic in situ hybridisation (ISH) in formalin-fixed, paraffin-embedded tissue specimens of human breast cancer and gastric cancer, including the gastro-oesophageal junction, following staining on VENTANA BenchMark instruments (BenchMark GX, BenchMark LT/XT, The INFORM HER2 Dual ISH DNA Probe Cocktail is indicated as an aid in the assessment of patients for whom Herceptin (trastuzumab) treatment is being considered. This product should be interpreted by a qualified reader in conjunction with histological examination, relevant clinical information and proper controls. This reagent is intended for in vitro diagnostic () use. HER2 clusters and Chr17 60X, amplified HER2 and Chr17 60X, non-amplified INFORM IGF1R Probe Assay Product Part Number INFORM IGF1R DNP Probe 800-4458 05994934001 25 tests INFORM Chromosome 15 DIG Probe 800-4459 05994926001 25 tests ultraview SISH DNP Detection Kit 800-098 05907136001 100 tests ultraview Red ISH DIG Detection Kit 800-505 05907128001 100 tests HybReady 780-4409 05917557001 250 dispenses ultraview Silver Wash II 780-003 05446724001 2L IGF1R ISH Xenograft Slides 783-4458 05994977001 10 slides The INFORM IGF1R DNP Probe and INFORM Chromosome 15 DIG Probe are designed to quantitatively detect amplification by light microscopy of the IGF1R gene via two colour chromogenic in situ hybridisation (ISH) in formalin-fixed, paraffin-embedded human tissue specimens, following staining on VENTANA BenchMark instruments (BenchMark GX, BenchMark LT/XT, Genomic gain of IGF1R is associated with non-small cell lung cancer (NSCLC). The IGF1R gene is located on chromosome 15 (15q26.3) and encodes the insulin-like growth factor-1 receptor protein. This product should be interpreted by a qualified reader in conjunction with histological examination, relevant clinical information and proper controls. This reagent is intended for in vitro diagnostic () use.

DNP Labelled Gene Probes EGFR DNP Probe NEW Part Number 980-1216 06443834001 One 1.25 ml vial of EGFR DNP Probe contains approximately 40 μg/ml of the probe labelled with DNP Chromosome 7 DIG Probe The EGFR DNP Probe is designed to hybridise to an approximately 955 Kb region of Chromosome 7 that includes the EGFR gene in FGFR1 DNP Probe NEW Part Number 980-1217 06454216001 One 1.25 ml vial of FGFR1 DNP Probe contains approximately 40 μg/ml of the probe labelled with DNP Chromosome 8 DIG Probe The FGFR1 DNP Probe is designed to hybridise to an approximately 505 Kb region of chromosome 8 that includes the FGFR1 gene in MDM2 DNP Probe NEW Part Number 980-1229 06683215001 One 1.25 ml vial of MDM2 DNP Probe contains approximately 40 μg/ml of the probe labelled with DNP Chromosome 12 DIG Probe The MDM2 DNP Probe is designed to hybridise to an approximately 628 Kb region of chromosome 12 that includes the MDM2 gene in formalin-fixed, paraffin-embedded human tissue specimens following staining on VENTANA BenchMark instruments (BenchMark MET DNP Probe NEW Part Number 980-1228 06641695001 One 1.25 ml vial of MET DNP Probe contains approximately 40 μg/ml of the probe labelled with DNP Chromosome 7 DIG Probe The MET DNP Probe is designed to hybridise to an approximately 506 Kb region of chromosome 7 that includes the MET gene in MYC DNP Probe NEW Part Number 980-1218 06454267001 One 1.25 ml vial of MYC DNP Probe contains approximately 40 μg/ml of the probe labelled with DNP Chromosome 8 DIG Probe The MYC DNP Probe is designed to hybridise to an approximately 496 Kb region of chromosome 8 that includes the MYC gene in VENTANA part number in black, Roche item number in blue.

DNP Labelled Gene Probes (cont.) PIK3CA DNP Probe NEW Part Number 980-1226 06620400001 One 1.25 ml vial of PIK3CA DNP Probe, contains approximately 40 μg/ml of the probe labelled with DNP Chromosome 3 DIG Probe The PIK3CA DNP Probe is designed to hybridise to an approximately 766 Kb region of chromosome 3 that includes the PIK3CA gene in PTEN DNP Probe NEW Part Number 980-1225 06621066001 One 1.25 ml vial of PTEN DNP Probe contains approximately 40 μg/ml of the probe labelled with DNP, Chromosome 10 DIG Probe The PTEN DNP Probe is designed to hybridise to an approximately 360 Kb region of chromosome 10 that includes the PTEN gene in TOP2A DNP Probe NEW Part Number 980-1227 06621112001 One 1.25 ml vial of TOP2A DNP Probe contains approximately 40 μg/ml of the probe labelled with DNP Chromosome 17 DIG Probe The TOP2A DNP Probe is designed to hybridise to an approximately 500 Kb region of chromosome 17 that includes the TOP2A gene in DIG Labelled Chromosome Probes Chromosome 3 DIG Probe NEW Part Number 980-1222 06577229001 One 1.25 ml vial of Chromosome 3 DIG Probe contains approximately 3.5 μg/ml of the probe labelled The Chromosome 3 DIG Probe is designed to hybridise to the centromeric region of chromosome 3 in formalin-fixed, paraffinembedded Chromosome 7 DIG Probe NEW Part Number 980-1219 06443915001 One 1.25 ml vial of Chromosome 7 DIG Probe contains approximately 8 μg/ml of the probe labelled The Chromosome 7 DIG Probe is designed to hybridise to the centromeric region of chromosome 7 in formalin-fixed, paraffinembedded VENTANA part number in black, Roche item number in blue.

DIG Labelled Chromosome Probes (cont.) Chromosome 8 DIG Probe NEW Part Number 980-1220 06453805001 One 1.25 ml vial of Chromosome 8 DIG Probe contains approximately 4 μg/ml of the probe labelled The Chromosome 8 DIG Probe is designed to hybridise to the centromeric region of chromosome 8 in formalin-fixed, paraffinembedded Chromosome 10 DIG Probe NEW Part Number 980-1223 06577369001 One 1.25 ml vial of Chromosome 10 DIG Probe contains approximately 4 μg/ml of the probe labelled The Chromosome 10 DIG Probe is designed to hybridise to the centromeric region of chromosome 10 in formalin-fixed, paraffinembedded Chromosome 12 DIG Probe NEW Part Number 980-1221 06577296001 One 1.25 ml vial of Chromosome 12 DIG Probe contains approximately 3 μg/ml of the probe labelled The Chromosome 12 DIG Probe is designed to hybridise to the centromeric region of chromosome 12 in formalin-fixed, paraffinembedded Chromosome 17 DIG Probe NEW Part Number 980-1224 06577067001 One 1.25 ml vial of Chromosome 17 DIG Probe contains approximately 2.5 μg/ml of the probe labelled The Chromosome 17 DIG Probe is designed to hybridise to the centromeric region of chromosome 17 in formalin-fixed, paraffinembedded

EBER, Kappa, and Lambda Probes INFORM EBER Probe Part Number 800-2842 05278660001 To be used with ISH iview Blue Detection Kit EBER Positive Specimen Slides INFORM EBER Probe is a fluorescein-labelled oligonucleotide probe intended to identify cells expressing Epstein-Barr encoded RNA (EBER) in sections of formalin-fixed, paraffin-embedded tissue using ISH iview Blue Detection Kit and other reagents on the VENTANA BenchMark instruments (BenchMark GX, BenchMark LT/XT, INFORM EBER Probe specifically hybridises to EBER RNA transcripts. Positive results aid in the identification of cells infected with Epstein-Barr virus. INFORM Kappa Probe Part Number 800-2843 05278678001 To be used with ISH iview Blue Detection Kit Kappa Positive Specimen Slides INFORM Kappa Probe is a fluorescein-labelled oligonucleotide probe intended to detect cytoplasmic mrna for kappa immunoglobulin light chain in formalin-fixed, paraffin-embedded tissue samples using ISH iview Blue Detection Kit and other reagents on the VENTANA BenchMark instruments (BenchMark GX, BenchMark LT/XT, INFORM Kappa Probe is typically used in conjunction with the INFORM Lambda Probe for lambda immunoglobulin light chain. The combined assays assist distinction between polyclonal (kappa positive, lambda positive mrna) proliferations associated with benign reactive plasma cell and B-cell lymphoid proliferations; and monoclonal (either kappa positive and lambda negative or kappa negative and lambda positive) proliferations associated with neoplastic plasma cell and B-cell lymphoid proliferations. INFORM Lambda Probe Part Number 800-2844 05278686001 To be used with ISH iview Blue Detection Kit Lambda Positive Specimen Slides INFORM Lambda Probe is a fluorescein-labelled oligonucleotide probe intended to detect cytoplasmic mrna for lambda immunoglobulin light chain in formalin-fixed, paraffin-embedded tissue samples using ISH iview Blue Detection Kit and other reagents on the VENTANA BenchMark instruments (BenchMark GX, BenchMark LT/XT, INFORM Lambda Probe is typically used in conjunction with the INFORM Kappa Probe for kappa immunoglobulin light chain. The combined assays assist distinction between polyclonal (kappa positive, lambda positive mrna) proliferations associated with benign reactive plasma cell and B-cell lymphoid proliferations; and monoclonal (either kappa positive and lambda negative or kappa negative and lambda positive) proliferations associated with neoplastic plasma cell and B-cell lymphoid proliferations. VENTANA part number in black, Roche item number in blue.

HPV Probes INFORM HPV II Family 6 Probe (B) Part Number 800-2220 05278546001 To be used with ISH iview Blue Plus Detection Kit HPV Family 6 Control Slides INFORM HPV II Family 6 (B) contains a cocktail of labelled human papillomavirus (HPV) genomic probes. The probe cocktail has demonstrated positive hybridisation to the following low risk genotypes: 6 and 11. INFORM HPV II Family 6 (B) Probe is to be used in conjunction with ISH iview Blue Plus Detection Kit and other reagents to stain formalin-fixed, paraffin-embedded tissue on the VENTANA BenchMark instruments (BenchMark GX, BenchMark LT/ XT, INFORM HPV III Family 16 Probe (B) Part Number 800-4295 05278856001 To be used with ISH iview Blue Plus Detection Kit HPV 3 in 1 System Control Slides INFORM HPV III Family 16 (B) contains a cocktail of labelled human papillomavirus (HPV) genomic probes. The intended targets are the common genital HPV genotypes found to be associated with cervical cancer. The probe cocktail has demonstrated positive hybridisation to the following genotypes: 16, 18, 31, 33, 35, 45, 51, 52, 56, 58 and 66. INFORM HPV III Family 16 (B) Probe is to be used in conjunction with ISH iview Blue Plus Detection Kit and other reagents to stain formalin-fixed, paraffin-embedded tissue on the VENTANA BenchMark instruments (BenchMark GX, BenchMark LT/XT,

Roche Diagnostics (Schweiz) AG Industriestrasse 7 CH-6343 Rotkreuz Switzerland Tel: +41 (0)41 799 61 00 www.roche.com www.ventana.com 2012 Ventana Medical Systems, Inc. and Roche Diagnostics International Ltd VENTANA, the VENTANA logo, BenchMark, INFORM, and ultraview are trademarks of Roche. E3052_0812C VENTANA Empowering Innovation